Luseogliflozin

Chemical formula: C₂₃H₃₀O₆S  Molecular mass: 434.176 g/mol  PubChem compound: 11988953

Therapeutic indications

Luseogliflozin is indicated for:

Diabetes mellitus type 2

Population group: only adults (18 years old or older)

Luseogliflozin is indicated in the treatment of type 2 diabetes mellitus to improve glycemic control in adults as:

Monotherapy

When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.

Add-on combination therapy

In combination with glucose-lowering medicinal products including insulin preparations in adult patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise plus monotherapy does not provide adequate glycemic control.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Luseogliflozin is contraindicated in the following cases:

Moderate renal impairment, severe renal impairmen

at least one of



Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe ketosis, diabetic coma, diabetic pre-coma

at least one of
Ketosis
Coma due to diabetes mellitus

Severe infection, surgeries, serious trauma

at least one of
Infectious disease
Surgical procedure
Traumatic injury

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.